RHOA and neoplasm: Tamoxifen inhibits the myofibroblastic differentiation of pancreatic stellate cells (PSCs) in the tumor microenvironment of pancreatic cancer in an acto‐myosin‐dependent manner via RhoA‐mediated contractility, YAP deactivation, and GPER signaling.